Education
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
Earnings Data
Report Date
May 06, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.26Last Year’s EPS
0.35Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: 5.82%
|Next Earnings Date:May 06, 2025
Earnings Call Sentiment|Positive
TransMedics' earnings call reflects strong financial performance and market share gains, particularly in the U.S., with significant revenue growth and operational improvements. However, there are challenges in gross margin, international revenue, and potential operational hurdles. The company has addressed recent allegations but faces variability in logistics and clinical program timelines.Company Guidance
During the TransMedics Fourth Quarter and Full Year 2024 Earnings Conference Call, the company provided guidance for 2025, projecting total revenue between $530 million and $552 million, implying a 20% to 25% growth over 2024. The call detailed TransMedics’ strong performance in 2024, with total revenue reaching $441.5 million, an 83% increase from 2023. The U.S. market drove this growth, with revenue surging to $422 million, a 91% increase. Operational highlights for Q4 included total revenue of $121.6 million, a year-over-year growth of approximately 50%, and a sequential increase of 12%. The company also achieved an overall gross margin of 59% and an operating profit of $8.6 million for the quarter. For 2024, the gross margin stood at 59.4%, slightly down from 63.8% in 2023 due to the higher contribution of service revenue. TransMedics demonstrated strong operational leverage, achieving a full-year operating profit of $37.5 million, marking its first year of positive cash flow from operating activities with $48.8 million generated. The company anticipates continued growth, driven by increased Organ Care System (OCS) adoption and service revenue, and plans to further invest in its next-generation technology platform and business infrastructure to ensure scalability.Record Revenue Growth
Total revenue for Q4 2024 was $121.6 million, representing approximately 50% growth year-over-year and 12% sequential growth from Q3 2024. Full year 2024 revenue was $441.5 million, an 83% growth over 2023.
Strong U.S. Performance
U.S. revenue grew 11% sequentially to $117 million in Q4 2024, while full year U.S. revenue reached $422 million, representing approximately 91% growth over 2023.
Operating Profit and Cash Flow
TransMedics delivered an operating profit of $8.6 million in Q4 2024 and $37.5 million for the full year, marking its first year of positive cash flow from operating activities, generating $48.8 million.
Increased Market Share in Organ Transplants
OCS U.S. market share across all three organs was 20.9% for full year 2024, up from 13.8% in 2023. Liver market share increased from 17% to 27%, heart market share from 16% to 19%.
Expansion of Logistics Infrastructure
TransMedics expanded its fleet to 19 aircraft by the end of Q4 2024, with plans to increase to 22 in 2025, improving logistics and operational efficiency.
---
TMDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TMDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $72.12 | $76.32 | +5.82% |
| Oct 28, 2024 | $126.24 | $88.50 | -29.90% |
| Jul 31, 2024 | $142.26 | $151.51 | +6.50% |
| Apr 30, 2024 | $94.13 | $117.60 | +24.93% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does TransMedics Group Inc (TMDX) report earnings?
TransMedics Group Inc (TMDX) is schdueled to report earning on May 06, 2025, TBA Not Confirmed.
What is TransMedics Group Inc (TMDX) earnings time?
TransMedics Group Inc (TMDX) earnings time is at May 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TMDX EPS forecast?
TMDX EPS forecast for the fiscal quarter 2025 (Q1) is 0.26.
---